Connection

Alireza Zali to Cetuximab

Back to Details
This is a "connection" page, showing publications Alireza Zali has written about Cetuximab.
Alireza Zali
Connection Strength
0.768
Cetuximab
  1. HER2+ mCRC patients with exon 20 R784G substitution mutation do not respond to the cetuximab therapy. J Cell Physiol. 2019 08; 234(8):13137-13144.
    View in: PubMed
    Score: 0.768
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.